BioCentury | May 2, 2020
Management Tracks
Catalent’s Boerman becomes president of cell and gene therapy; plus Stanford, Intellia, Cortexyme, CZ Biohub, Grail and more
...Intellia Therapeutics Inc. (NASDAQ:NTLA) hired David Lebwohl as EVP and CMO. He was CMO of Semma Therapeutics Inc....